Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-25,289
Closed -$31.4K 1086
2025
Q1
$31.4K Buy
+25,289
New +$37.5K ﹤0.01% 900
2023
Q2
Sell
-22,329
Closed -$43.1K 1320
2023
Q1
$43.1K Buy
22,329
+10,577
+90% +$26.5K ﹤0.01% 1339
2022
Q4
$24.7K Buy
+11,752
New +$26.6K ﹤0.01% 1230
2022
Q2
Sell
-17,068
Closed -$77K 1495
2022
Q1
$77K Buy
+17,068
New +$94K ﹤0.01% 1206
2020
Q4
Sell
-13,691
Closed -$253K 541
2020
Q3
$253K Buy
+13,691
New +$243K 0.02% 359
2019
Q4
Sell
-21,810
Closed -$227K 307
2019
Q3
$227K Buy
+21,810
New +$293K 0.03% 176
2019
Q1
Sell
-30,355
Closed -$505K 220
2018
Q4
$505K Buy
+30,355
New +$704K 0.05% 178
2018
Q3
Sell
-27,768
Closed -$786K 261
2018
Q2
$786K Buy
27,768
+20,182
+266% +$601K 0.09% 101
2018
Q1
$239K Buy
+7,586
New +$240K 0.03% 221
2017
Q1
Sell
-10,956
Closed -$186K 350
2016
Q4
$186K Buy
+10,956
New +$202K 0.01% 362
2016
Q1
Sell
-32,334
Closed -$1M 257
2015
Q4
$1M Buy
32,334
+14,354
+80% +$436K 0.13% 116
2015
Q3
$474K Buy
+17,980
New +$602K 0.07% 129

Other funds holding CLLS

Old Mission Capital's CLLS Position: Q2 2025 in Review

Old Mission Capital sold out of Cellectis (CLLS) in Q2 2025, closing a stake of 25,289 shares — an estimated $31.4K sold.

Old Mission Capital first reported a position in CLLS in Q3 2015 and held it in 12 quarters. The position peaked at $1M in Q4 2015. 24 funds tracked by Wall St. Rank hold CLLS as of Q2 2025.

  • Old Mission Capital reported no remaining Cellectis position as of Q2 2025 after selling out during the quarter.
  • Old Mission Capital sold 25,289 Cellectis shares in Q2 2025, an estimated $31.4K.
  • Old Mission Capital first reported a position in Cellectis in Q3 2015 and held it in 12 quarters.
  • Old Mission Capital's Cellectis position peaked at $1M in Q4 2015.
  • 24 funds tracked by Wall St. Rank held Cellectis as of Q2 2025.

Based on Old Mission Capital's 13F filing for Q2 2025, filed 14 Aug 2025.